UK Markets open in 3 hrs 20 mins

CompuGroup Medical SE & Co. KGaA (0MSD.IL)

IOB - IOB Delayed price. Currency in EUR
Add to watchlist
36.48-1.12 (-2.97%)
At close: 06:00PM BST
Full screen
Previous close37.60
Open36.82
Bid0.00 x 0
Ask0.00 x 0
Day's range35.64 - 36.82
52-week range35.64 - 77.55
Volume11,186
Avg. volume19,268
Market cap1.901B
Beta (5Y monthly)1.04
PE ratio (TTM)30.55
EPS (TTM)1.19
Earnings dateN/A
Forward dividend & yield0.50 (1.18%)
Ex-dividend date20 May 2022
1y target estN/A
  • EQS Group

    CompuGroup Medical confirms mid-term ambition at the Capital Markets Day

    DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): MiscellaneousCompuGroup Medical confirms mid-term ambition at the Capital Markets Day 01.09.2022 / 09:48 CET/CESTThe issuer is solely responsible for the content of this announcement. CGM well on track for strong revenue growth in 2022 Mid-term organic revenue growth of more than 5 % CAGR reconfirmed Adjusted EBITDA Margin improvement post investment phase towards 27 % by 2025 Every segment delivers on revenue growth and margin expansion

  • EQS Group

    CompuGroup Medical delivers across all segments – guidance 2022 raised

    DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Half Year ResultsCompuGroup Medical delivers across all segments – guidance 2022 raised 04.08.2022 / 07:23 The issuer is solely responsible for the content of this announcement. 10 % growth in first half of 2022 with revenues of EUR 517 million 8 % growth in adjusted EBITDA after first six months of 2022 Growing share of recurring revenues at 69 % underlines resilience of business model Guidance for 2022 raised and mid-term targets confi

  • EQS Group

    CompuGroup Medical appoints CFO Michael Rauch as Spokesman for the Managing Directors

    DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): PersonnelCompuGroup Medical appoints CFO Michael Rauch as Spokesman for the Managing Directors 02.06.2022 / 21:04 The issuer is solely responsible for the content of this announcement. Administrative Board and CEO Dr. Dirk Wössner mutually agree on termination of contract as of June 30, 2022 CFO Michael Rauch is appointed Spokesman of the Managing Directors as primus inter pares and takes a seat on the Administrative Board Reduction of t